Historical Information on Positron Emission Tomography (PET)

On November 21, 1997, the President signed the Food and Drug Administration Modernization Act of 1997 (Modernization Act). Section 121 of the Modernization Act included provisions that directed FDA to establish appropriate procedures for the approval of positron emission tomography (PET) drugs and appropriate current good manufacturing practice requirements for such drugs. FDA has begun developing those procedures and has established this site to provide information on these activities.

Drug Approvals


Federal Register Notices





Public Meeting, May 21, 2002, 9 a.m., Rockville, Maryland  

Public Meeting, July 28, 2000, Gaithersburg, Maryland

Public Meeting, March 22, 2000, Gaithersburg, Maryland

Eleventh Annual Pet Conference, October 26, 1999, Vancouver, Canada

  Public Meeting, September 28, 1999, Gaithersburg, Maryland



Page Last Updated: 12/17/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English